Curated News
By: NewsRamp Editorial Staff
June 12, 2026

LIXTE Biotech Acquires NOMAD Power, Pivots to Energy Storage

Discuss on LinkedIn Discuss on Substack Discuss on Telegram participate in discussion on bluesky Participate in discussion on Mastodon View History of this news story on GitHub
Original Source

TLDR

  • LIXTE acquires NOMAD for rapid-deploy battery storage, targeting AI-driven power demand with 175% revenue growth.
  • NOMAD's mobile 1 MW battery systems bypass permitting delays, enabling faster grid deployment than permanent installations.
  • Acquisition aims to solve power shortages from AI and reshoring, supporting reliable energy for communities.
  • NOMAD's transportable batteries can be deployed quickly, avoiding typical interconnection delays of permanent setups.

Impact - Why it Matters

This news matters because it highlights the growing urgency of grid-scale energy storage to support AI, electrification, and reshoring. LIXTE's pivot from biotech to energy storage signals that companies are betting big on power infrastructure as a critical bottleneck for economic growth. For investors and industry watchers, the acquisition offers a unique chance to participate in a high-growth energy sector while retaining biotech upside, but it also introduces execution risks as the company transitions to a new market. The success of NOMAD's rapid-deployment model could set a precedent for how utilities and industries address power shortages without lengthy permitting delays.

Summary

In a strategic pivot from biotechnology to energy, LIXTE Biotechnology Holdings (NASDAQ: LIXT) has announced a definitive agreement to acquire 100% of NOMAD Transportable Power Systems, a leader in deployable, utility-grade battery energy storage. The combined entity will be renamed NOMAD Power Solutions, reflecting a new focus on addressing critical power availability challenges driven by artificial intelligence, electrification, manufacturing reshoring, and grid modernization. This acquisition marks a significant departure from LIXTE's core business of cancer drug development, but management believes the move positions the company to capitalize on the surging demand for grid-scale power infrastructure.

NOMAD pioneered the mobile, utility-grade 1 MW battery energy storage system market and serves a diverse customer base including utilities, cooperatives, municipalities, and large industrial users. The company has demonstrated impressive growth, reporting approximately 175% year-over-year revenue growth in 2025 and projecting an additional 135% increase in 2026. NOMAD’s transportable energy storage systems offer rapid deployment while bypassing many of the permitting and interconnection delays typical of permanent installations, giving the company a competitive edge as demand for power infrastructure accelerates across North America. This acquisition allows LIXTE to pivot into a high-growth sector while retaining its biotechnology operations, including its lead compound LB-100 and its subsidiary Liora Technologies, which develops proton therapy systems.

The transaction underscores a broader trend of companies diversifying into energy solutions to meet escalating power needs. LIXTE's clinical-stage pharmaceutical business will continue under the new corporate structure, but the focus is clearly on scaling NOMAD's energy storage business. For investors, this deal offers exposure to both the renewable energy storage market and ongoing cancer drug development, though the success of the pivot will depend on execution and market adoption. The full press release is available at https://ibn.fm/hiRnl.

Source Statement

This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, LIXTE Biotech Acquires NOMAD Power, Pivots to Energy Storage

blockchain registration record for this content.